A detailed history of Menard Financial Group LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Menard Financial Group LLC holds 2,869 shares of MRK stock, worth $285,522. This represents 0.22% of its overall portfolio holdings.

Number of Shares
2,869
Previous 2,799 2.5%
Holding current value
$285,522
Previous $346,000 6.07%
% of portfolio
0.22%
Previous 0.26%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$111.15 - $128.97 $7,780 - $9,027
70 Added 2.5%
2,869 $325,000
Q2 2024

Aug 09, 2024

BUY
$123.8 - $132.96 $990 - $1,063
8 Added 0.29%
2,799 $346,000
Q1 2024

May 13, 2024

BUY
$113.24 - $131.95 $4,076 - $4,750
36 Added 1.31%
2,791 $368,000
Q3 2023

Nov 14, 2023

BUY
$102.95 - $114.33 $37,473 - $41,616
364 Added 15.22%
2,755 $283,000
Q2 2023

Aug 14, 2023

BUY
$108.61 - $118.38 $34,646 - $37,763
319 Added 15.4%
2,391 $275,000
Q1 2023

May 12, 2023

BUY
$102.94 - $114.86 $720 - $804
7 Added 0.34%
2,072 $220,000
Q4 2022

Feb 14, 2023

SELL
$87.44 - $112.11 $78,958 - $101,235
-903 Reduced 30.42%
2,065 $229,000
Q3 2022

Nov 14, 2022

SELL
$84.53 - $94.96 $58,325 - $65,522
-690 Reduced 18.86%
2,968 $256,000
Q2 2022

Aug 15, 2022

BUY
$83.49 - $94.64 $305,406 - $346,193
3,658 New
3,658 $333,000
Q4 2020

Feb 09, 2021

SELL
$71.77 - $79.65 $268,635 - $298,129
-3,743 Closed
0 $0
Q3 2020

Nov 12, 2020

SELL
$73.18 - $82.95 $10,098 - $11,447
-138 Reduced 3.56%
3,743 $310,000
Q2 2020

Aug 13, 2020

BUY
$70.42 - $80.13 $273,300 - $310,984
3,881 New
3,881 $300,000
Q1 2020

May 15, 2020

SELL
$63.36 - $87.82 $437,690 - $606,660
-6,908 Closed
0 $0
Q4 2019

Feb 13, 2020

BUY
$77.58 - $87.54 $535,922 - $604,726
6,908 New
6,908 $628,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $252B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Menard Financial Group LLC Portfolio

Follow Menard Financial Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Menard Financial Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Menard Financial Group LLC with notifications on news.